十一月 2025
- Home
- Ajinomoto Bio-Pharma Services
十一月 2025的Ajinomoto Bio-Pharma Ser...市场份额分析
Forge Biologics, a member of Ajinomoto Bio-Pharma Services, offers comprehensive AAV and plasmid manufacturing services from preclinical stage through clinical and onto commercial manufacturing.
Ajinomoto Bio-Pharma Services(包含公司地区分支机构)
查看更多网站流量和参与度信息- ajibio-pharma.com
Ajinomoto Bio-Pharma Services收入截至 十一月 2025为 200M - 500M
Ajinomoto Bio-Pharma Services主要域名产生的收入
3 年中Ajinomoto Bio-Pharma Services主要域名的收入
Ajinomoto Bio-Pharma Services主要域名的收入
Ajinomoto Bio-Pharma Services热门域名的总访问量
了解Ajinomoto Bio-Pharma Services市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Ajinomoto Bio-Pharma Services热门域名的平均访问时长
分析Ajinomoto Bio-Pharma Services参与度指标。
过去 3 个月的平均访问时长
子公司明细
Ajinomoto Bio-Pharma Services热门域名的平均页面浏览量
了解Ajinomoto Bio-Pharma Services如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Ajinomoto Bio-Pharma Services 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Aji Bio-Pharma attends event 12th Annual World ADC Awards.TOKYO, Nov. 17, 2025 /PRNewswire/ - Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it has been named the winner of the "Best ADC Preclinical Publication 2024" at the 12th Annual World ADC Awards, recognizing the company's innovative research publication on the AJICAP(R) linker technology.
十一月 17, 2025阅读更多
新闻Gene Tools, LLC integrates with Aji Bio-Pharma."By combining Gene Tools' long-standing expertise in early-stage PMO synthesis with Aji Bio-Pharma's proven capabilities in purification and large-scale manufacturing, we are providing our customers with continuity and confidence as they move from discovery toward clinical development."
十月 21, 2025阅读更多
查看 Ajinomoto Bio-Pharma Services 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。